Ensuring national food security is an eternal topic. We unified six categories of food with calorie content including grain, oil, sugar, fruits and vegetables, animal husbandry, and aquatic products on the basis of provincial-level data, and we dynamically evaluated caloric production capacity and the supply-demand equilibrium under the increase in feed-grain consumption as well as the food losses and waste in China from 1978 to 2020 at four different levels. The results show that: (1) From the perspective of food production, the total national calorie production showed a linear growth trend, with a growth rate of 31.7 × 10 kcal/year, of which the proportion of grain crops has always exceeded 60%. Most provinces showed significant increasing trends in food calorific production, except for Beijing, Shanghai, and Zhejiang, which showed slightly decreasing trends. The distribution pattern of food calories and their growth rate were high in the east and low in the west. (2) From the perspective of the food supply-demand equilibrium, the national food calorie supply has been in surplus since 1992, but significant spatial heterogeneity is detected, with the Main Marketing Region changing from a tight balance to a short surplus, North China always remaining in calorie shortage, and 15 provinces still presenting supply and demand gaps up to 2020, necessitating the establishment of a more efficient and faster flow and trade system. (3) The national food caloric center has shifted 204.67 km to the northeast, and the population center has shifted to the southwest. The reverse migration of the centers of food supply and demand will further aggravate the pressure on water and soil resources and cause higher requirements for ensuring the circulation and trade system of food supply. The results are of great significance for the timely adjustment of agricultural development policies, making rational use of natural advantages and ensuring China's food security and sustainable agricultural development.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001151 | PMC |
http://dx.doi.org/10.3390/foods12050956 | DOI Listing |
Alzheimers Dement
December 2024
Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, U.S.A., Philadelphia, PA, USA.
Background: The vicious cycle between depression and dementia increases the risk of Alzheimer's Disease (AD) pathogenesis and pathology. This study investigates therapeutic effectiveness versus side effects and the underlying mechanisms of intranasal dantrolene nanoparticles (IDNs) to treat depression behavior and memory loss in 5XFAD mice.
Method: 5XFAD and wild-type B6SJLF1/J mice were treated with IDNs (IDN, 5 mg/kg) in Ryanodex formulation for a duration of 12 weeks.
Alzheimers Dement
December 2024
Edith Cowan University, Perth, Western Australia, Australia.
Background: Accumulation of amyloid beta 42 (Aβ42) senile plaques is the most critical event leading to Alzheimer's disease (AD). Currently approved drugs for AD have not been able to effectively modify the disease. This has caused increasing research interests in health beneficial nutritious plant foods as viable alternative therapy to prevent or manage AD.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Background: In preparation for therapeutic trails involving patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI), there is a need for valid, disease-specific caregiver-reported outcome (CRO) measures capable of tracking symptomatic burden in response to therapy over time. CROs are useful tools in clinical trials for individuals with AD, MCI, and dementia who are unable to self-report. In addition, CROs are accepted by the United States Food and Drug Administration to support regulatory claims.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Merry Life Biomedical Company, Ltd., Tainan City, Taiwan, Taiwan.
Background: Alzheimer's disease (AD) is complex in pathogenesis and related to aging biology, especially in late-onset AD. We identified a novel synthetic curcumin analog TML-6 through the platform of 6 biomarkers of anti-aging, anti-inflammation, and anti-Aβ as the potential AD drug candidate. TML-6 exhibits multi-target effects on AD pathogenesis, including the activation of NrF-2, the regulation of autophagic machinery through mTOR, the inhibition of APP synthesis and reduction of Aβ, the upregulation of ApoE, and the inhibition of microglial activation.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.
Background: Alzheimer disease (AD) is a progressive neurodegenerative disease that is accountable for the leading case of dementia in elder people. Before, only symptomatic treatments are available for AD. Since 2021, two anti-amyloid antibodies aducanumab and lecanemab have been approved by the US Food and Drug Administration.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!